The 10-day RSI Indicator for IRIX moved out of overbought territory on October 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 22 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 88%.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRIX as a result. In 79 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for IRIX turned negative on October 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 31 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
IRIX moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IRIX crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for IRIX entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRIX advanced for three days, in 151 of 203 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
IRIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.955) is normal, around the industry mean (4.142). P/E Ratio (-3.330) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (3.870) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. IRIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MOBI saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator turned positive. In 5 of the 5 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for MOBI just turned positive on October 19, 2026. Looking at past instances where MOBI's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
MOBI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +13.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOBI advanced for three days, in 20 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MOBI entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.158) is normal, around the industry mean (4.142). P/E Ratio (-5.807) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (7.874) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. MOBI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
IRIX | MOBI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 28 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 43 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 77 | 36 | |
P/E GROWTH RATING 1..100 | 16 | 35 | |
SEASONALITY SCORE 1..100 | 50 | 29 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MOBI's Valuation (28) in the Packaged Software industry is somewhat better than the same rating for IRIX (73) in the Medical Specialties industry. This means that MOBI’s stock grew somewhat faster than IRIX’s over the last 12 months.
MOBI's Profit vs Risk Rating (43) in the Packaged Software industry is somewhat better than the same rating for IRIX (100) in the Medical Specialties industry. This means that MOBI’s stock grew somewhat faster than IRIX’s over the last 12 months.
MOBI's SMR Rating (97) in the Packaged Software industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that MOBI’s stock grew similarly to IRIX’s over the last 12 months.
MOBI's Price Growth Rating (36) in the Packaged Software industry is somewhat better than the same rating for IRIX (77) in the Medical Specialties industry. This means that MOBI’s stock grew somewhat faster than IRIX’s over the last 12 months.
IRIX's P/E Growth Rating (16) in the Medical Specialties industry is in the same range as MOBI (35) in the Packaged Software industry. This means that IRIX’s stock grew similarly to MOBI’s over the last 12 months.
| IRIX | MOBI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 88% | N/A |
| Stochastic ODDS (%) | 3 days ago 77% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 81% | 3 days ago 90% |
| MACD ODDS (%) | 3 days ago 79% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 75% | 3 days ago 86% |
| TrendMonth ODDS (%) | 3 days ago 82% | 3 days ago 88% |
| Advances ODDS (%) | 19 days ago 74% | 11 days ago 90% |
| Declines ODDS (%) | 5 days ago 80% | 3 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 86% | N/A |
| Aroon ODDS (%) | 3 days ago 80% | 3 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRIX’s FA Score shows that 1 FA rating(s) are green while MOBI’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRIX’s TA Score shows that 3 TA indicator(s) are bullish while MOBI’s TA Score has 4 bullish TA indicator(s).
IRIX (@Medical/Nursing Services) experienced а +0.14% price change this week, while MOBI (@Medical/Nursing Services) price change was +17.69% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.
IRIX is expected to report earnings on Nov 17, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.
| Ticker / NAME | Correlation To IRIX | 1D Price Change % | ||
|---|---|---|---|---|
| IRIX | 100% | -4.78% | ||
| NTRA - IRIX | 30% Poorly correlated | -1.19% | ||
| NEO - IRIX | 27% Poorly correlated | -3.14% | ||
| IQV - IRIX | 27% Poorly correlated | -2.21% | ||
| MDXH - IRIX | 26% Poorly correlated | +2.93% | ||
| DRIO - IRIX | 26% Poorly correlated | -23.64% | ||
More | ||||
A.I.dvisor tells us that MOBI and IART have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOBI and IART's prices will move in lockstep.
| Ticker / NAME | Correlation To MOBI | 1D Price Change % | ||
|---|---|---|---|---|
| MOBI | 100% | -1.05% | ||
| IART - MOBI | 7% Poorly correlated | +0.35% | ||
| LAB - MOBI | 3% Poorly correlated | +8.60% | ||
| BRKR - MOBI | 1% Poorly correlated | +2.09% | ||
| IRIX - MOBI | 1% Poorly correlated | -4.78% | ||
| BIO - MOBI | -3% Poorly correlated | -1.11% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LCF | 45.47 | 0.09 | +0.19% |
| Touchstone US Large Cap Focused ETF (LCF) | |||
| IEFA | 96.89 | 0.13 | +0.13% |
| iShares Core MSCI EAFE ETF (IEFA) | |||
| PAPR | 43.32 | -0.03 | -0.07% |
| Innovator U.S. Equity Power Buffer ETF - April (PAPR) | |||
| UAUG | 42.84 | -0.05 | -0.11% |
| Innovator U.S. Equity Ultra Buffer ETF - August (UAUG) | |||
| VBCH | 71.93 | -0.15 | -0.22% |
| Vanguard Target Maturity 2034 Corporate Bond ETF (VBCH) | |||